RE:RE:RE:RE:RE:RE:MEDXF gets CRLIf you had 100% safe cure for cancer FDA would reject it because they look at how it would effect big pharma. Why the road block to list on Nasdaq? Who was pulling strings in the background to keep MDP off the Nasdaq?
Here is what Ken said
"
"In the fourth quarter of fiscal 2021, IXINITY sales declined as pharmacy and wholesale customers worked through inventory on hand. In addition, an unexpected manufacturing expense related to the Pediatric Trial of IXINITY impacted our Adjusted EBITDA. We do not expect this issue to affect the timing for completion of the trial. With a goal of long-term margin improvement, we are working with our manufacturing partners to improve the supply chain and manufacturing process in order to meet the unit demand for IXINITY, which grew by more than 15% in the year-ended March 31, 2021."
"We continue to evaluate significant in-licensing opportunities that we believe will enable us to further leverage our North American infrastructure. During the year we strengthened our business development team and sharpened our focus on US centric opportunities. This means an increased focus on Rare, Orphan, and Autoimmune disease. As part of our growth strategy, we were pleased to announce an uplisting to the TSX earlier this week. We believe that a listing on a Tier 1 exchange will also help maximize value for our shareholders and increase our profile and liquidity in the market. Additionally, we are confident that graduating to a senior exchange will provide us with access to a broader range of institutional shareholders. We will continue to evaluate the timing of a dual-listing on the Nasdaq as we advance several ongoing business initiatives."
This FDA decision stinks and they have no basis for their conclusion.